Patents by Inventor Michael David Bell
Michael David Bell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11896695Abstract: According to the present invention there is provided composition in the form of an oil-in-water emulsion having a viscosity of between 15,000 cP (15 Pa-s) and 45,000 cP (45 Pa-s) at 23° C., having a pH of between 2 and 6 and comprising: (i) at least 1.6 wt. % of at least one cross-linked anionic polyelectrolyte resulting from the polymerisation of partially or completely salified 2-methyl 2-[(1-oxo 2-propenyl)amino]1-propane sulfonic acid, with at least one neutral monomer chosen from the N,N-dialkyl acrylamides, wherein each of the alkyl groups comprises between one and four carbon atoms, and at least one monomer of formula (B): wherein R represents a linear or branched alkyl radical comprising eight to twenty carbon atoms and n represents a number greater than or equal to one and less than or equal to twenty, in the presence of at least one cross-linking agent; (ii) at least 4 wt. % of at least one polysorbate; (iii) at least 0.1 wt. % of at least one polysaccharide gum; and (iv) between 6 wt. % and 30 wt.Type: GrantFiled: August 5, 2019Date of Patent: February 13, 2024Assignee: THE BOOTS COMPANY PLCInventors: Jake Thomas Hicks, Marco Demurtas, Christopher John Elms, Paul James Tomlinson, Michael David Bell
-
Publication number: 20240009105Abstract: According to the present invention there is provided a peptide combination, capable of inducing dermal extracellular matrix protein upregulation, comprising; a) a first peptide selected from the group consisting of tetrapeptides having the amino acid sequence U-LSXX-Z; and b) a second peptide selected from the group consisting of tetrapeptides having the amino acid sequence U-GPXG-Z.Type: ApplicationFiled: November 16, 2021Publication date: January 11, 2024Inventors: Michael David Bell, Eleanor Jane Bradley, Yegor Doush, Michael John Sherratt, Matiss Ozols, Alexander Eckersley
-
Publication number: 20230416304Abstract: According to the present invention, there is provided a tetrapeptide, capable of inducing dermal extracellular matrix protein upregulation, selected from the group consisting of tetrapeptides having the amino acid sequence U-LSXX-Z wherein L is used to denote amino acid Leucine and S is used to denote Serine, as per the internationally recognised single letter code for amino acids, X denotes an amino acid selected from the group consisting of Valine (V), Aspartic acid (D), Proline (P), Glycine (G) and mixtures thereof, at the N-terminal end, U is selected from the group consisting of H, —CO—R1, —SO2—R1 or a biotinyl group, at the C-terminal end, Z is selected from the group consisting of OH, O R1, NHR1 or NR1R2; wherein if U is H then Z cannot be OH and R1 and R2 are independently selected from the group consisting of alkyl, aryl, aralkyl, alkylaryl, alkoxy, saccharide and aryloxy group, which may be linear, branched, cyclical, polycyclic, unsaturated, hydroxylates, carbonylated, phosphorylated and/or sulphurType: ApplicationFiled: November 16, 2021Publication date: December 28, 2023Inventors: Michael David Bell, Eleanor Jane Bradley, Yegor Doush, Michael John Sherratt, Matiss Ozols, Alexander Eckersley
-
Publication number: 20230414477Abstract: A tetrapeptide, capable of inducing dermal extracellular matrix protein upregulation, selected from the group consisting of tetrapeptides having the amino acid sequence U-QTAV-Z wherein Q denotes Glutamine, T denotes Threonine, A denotes Alanine and V denotes Valine, at the N-terminal end, U is independently selected from the group consisting of octanoyl (C8), decanoyl (C10), lauroyl (C12), myristoyl (C14), palmitoyl (C16), stearoyl (C18), biotinoyl, elaidoyl, oleoyle, lipoyle, at the C-terminal end, Z is selected from the group consisting of OH, O R1, NHR1 or NR1R2, R1 and R2 are independently selected from the group consisting of alkyl, aryl, aralkyl, alkylaryl, alkoxy, saccharide and aryloxy group, which may be linear, branched, cyclical, polycyclic, unsaturated, hydroxylates, carbonylated, phosphorylated and/or sulphurous, said groups comprising from 1 to 24 carbon atoms and being capable of including one or more heteroatoms O, S and/or N.Type: ApplicationFiled: November 16, 2021Publication date: December 28, 2023Inventors: Michael David Bell, Eleanor Jane Bradley, Yegor Doush, Michael John Sherratt, Matiss OZOLS, Alexander Eckersley
-
Publication number: 20230414476Abstract: According to the present invention, there is provided a tetrapeptide, capable of inducing dermal extracellular matrix protein upregulation, having the amino acid sequence U-(SEQ ID No: 1)-Z, U-(SEQ ID No: 2)-Z, U-(SEQ ID No: 3)-Z, U-(SEQ ID No: 4)-Z, U-(SEQ ID No: 5)-Z, U-(SEQ ID No: 6)-Z, U-(SEQ ID No: 7)-Z, U-(SEQ ID No: 8)-Z, U-(SEQ ID No: 9)-Z, U-(SEQ ID No: 11)-Z, U-(SEQ ID No: 12)-Z, U-(SEQ ID No: 13)-Z, U-(SEQ ID No: 14)-Z, U-(SEQ ID No: 15)-Z, U-(SEQ ID No: 16)-Z, U-(SEQ ID No: 17)-Z, U-(SEQ ID No: 18)-Z, U-(SEQ ID No: 19)-Z, U-(SEQ ID No: 20)-Z, U-(SEQ ID No: 21)-Z, U-(SEQ ID No: 22)-Z, U-(SEQ ID No: 23)-Z, U-(SEQ ID No: 24)-Z, U-(SEQ ID No: 25)-Z, U-(SEQ ID No: 26)-Z, U-(SEQ ID No: 27)-Z, U-(SEQ ID No: 28)-Z, and U-(SEQ ID No: 29)-Z.Type: ApplicationFiled: November 16, 2021Publication date: December 28, 2023Inventors: Michael David Bell, Eleanor Jane Bradley, Yegor Doush, Michael John Sherratt, Matiss Oaols, Alexander Eckersley
-
Publication number: 20210161781Abstract: According to the present invention there is provided composition in the form of an oil-in-water emulsion having a viscosity of between 15,000 cP (15 Pa-s) and 45,000 cP (45 Pa-s) at 23° C., having a pH of between 2 and 6 and comprising: (i) at least 1.6 wt. % of at least one cross-linked anionic polyelectrolyte resulting from the polymerisation of partially or completely salified 2-methyl 2-[(1-oxo 2-propenyl)amino]1-propane sulfonic acid, with at least one neutral monomer chosen from the N,N-dialkyl acrylamides, wherein each of the alkyl groups comprises between one and four carbon atoms, and at least one monomer of formula (B): wherein R represents a linear or branched alkyl radical comprising eight to twenty carbon atoms and n represents a number greater than or equal to one and less than or equal to twenty, in the presence of at least one cross-linking agent; (ii) at least 4 wt. % of at least one polysorbate; (iii) at least 0.1 wt. % of at least one polysaccharide gum; and (iv) between 6 wt. % and 30 wt.Type: ApplicationFiled: August 5, 2019Publication date: June 3, 2021Inventors: Jake Thomas Hicks, Marco Demurtas, Christopher John Elms, Paul James Tomlinson, Michael David Bell
-
Publication number: 20210077375Abstract: According to the present invention there is provided an aqueous concentrated cosmetic composition comprising at least 20% water, at least 4.5% by weight of the composition of humectant, at least 8% of the composition of a peptide and high levels of a skin benefit active(s).Type: ApplicationFiled: September 13, 2019Publication date: March 18, 2021Applicant: THE BOOTS COMPANY PLCInventors: Jake Thomas Hicks, Christopher John Elms, Michael David Bell
-
Publication number: 20190314648Abstract: The disclosed technology relates to a method of decreasing or preventing signs of ageing of décolleté skin and optionally the face and/or neck skin comprising topically applying to the skin a composition comprising a cosmetically acceptable medium, a vitamin C, or derivative thereof, and compound having two or more hydroxyl groups, wherein the compound has a molar mass of at least 150 g/mol and increases transglutaminase K expression in epidermal keratinocytes.Type: ApplicationFiled: June 27, 2017Publication date: October 17, 2019Inventors: Aneshkumar Dineshchandra Sitaram, Jake Thomas Hicks, Paul James Tomlinson, Michael David Bell
-
Patent number: 10335357Abstract: A water-in-oil emulsion comprising less than 60% water, and wherein said emulsion comprises an oil phase and a water phase, and wherein the water phase comprises a dipeptide selected from the group consisting of acetyl dipeptide (1) cetyl ester, acetyl dipeptide (3) aminohexanoate, azelaoyl bisdipeptide (10), coumaroyl dipeptide (3), dicetyl dipeptide (9), dipeptide diamino butyroyl benzylamide diacetate, dipeptide (1), dipeptide (10), dipeptide (11), dipeptide (12), dipeptide (15), dipeptide (16), dipeptide (17), dipeptide (18), dipeptide (19), dipeptide (2), dipeptide (20), dipeptide (3), dipeptide (4), dipeptide (5), dipeptide (6), dipeptide (7), dipeptide (8), dipeptide (8) HCL, dipeptide (9), hexanoyl dipeptide (3) norleucine acetate, methyl undecylenoyl dipeptide (16), nicotinoyl dipeptide (22), nicotinoyl dipeptide (23), nicotinoyl dipeptide (24), nicotinoyl dipeptide (26), oleoyl dipeptide (15), palmitoyl dipeptide (10), palmitoyl dipeptide (13), palmitoyl dipeptidel (7), palmitoyl dipeptide (5) diamiType: GrantFiled: May 15, 2014Date of Patent: July 2, 2019Assignee: THE BOOTS COMPANY PLCInventors: Paul James Tomlinson, Mark Johnson, Michael David Bell
-
Publication number: 20180110721Abstract: According to the present invention there is provided a cosmetic liquid composition comprising an antioxidant complex, said complex comprising at least one antioxidant polyphenolic agent, at least one vitamin E or a vitamin E derivative; and a chromane antioxidant.Type: ApplicationFiled: June 17, 2015Publication date: April 26, 2018Inventors: Michael David Bell, Clare Helena O'Connor
-
Publication number: 20170112758Abstract: The present invention provides a water-in-oil emulsion comprising less than 60% water, and wherein said emulsion comprises an oil phase and a water phase, and wherein the water phase comprises a matrix metalloproteinase inhibitor (MMPi) and a skin conditioning agent.Type: ApplicationFiled: May 15, 2014Publication date: April 27, 2017Inventors: Paul James Tomlinson, Mark Johnson, Michael David Bell
-
Publication number: 20170112744Abstract: A water-in-oil emulsion comprising less than 60% water, and wherein said emulsion comprises an oil phase and a water phase, and wherein the water phase comprises a dipeptide selected from the group consisting of acetyl dipeptide (1) cetyl ester, acetyl dipeptide (3) aminohexanoate, azelaoyl bisdipeptide (10), coumaroyl dipeptide (3), dicetyl dipeptide (9), dipeptide diamino butyroyl benzylamide diacetate, dipeptide (1), dipeptide (10), dipeptide (11), dipeptide (12), dipeptide (15), dipeptide (16), dipeptide (17), dipeptide (18), dipeptide (19), dipeptide (2), dipeptide (20), dipeptide (3), dipeptide (4), dipeptide (5), dipeptide (6), dipeptide (7), dipeptide (8), dipeptide (8) HCL, dipeptide (9), hexanoyl dipeptide (3) norleucine acetate, methyl undecylenoyl dipeptide (16), nicotinoyl dipeptide (22), nicotinoyl dipeptide (23), nicotinoyl dipeptide (24), nicotinoyl dipeptide (26), oleoyl dipeptide (15), palmitoyl dipeptide (10), palmitoyl dipeptide (13), palmitoyl dipeptidel (7), palmitoyl dipeptide (5) diamiType: ApplicationFiled: May 15, 2014Publication date: April 27, 2017Applicant: THE BOOTS COMPANY PLCInventors: Paul James Tomlinson, Mark Johnson, Michael David Bell
-
Publication number: 20030113357Abstract: The present invention relates to a topical cosmetic composition with an aqueous continuous phase, in the form of a lotion, cream or gel, comprising:Type: ApplicationFiled: November 22, 2002Publication date: June 19, 2003Applicant: The Procter & Gamble CompanyInventors: Michael David Bell, Russell Philip Elliott